Diagnosing and Managing Steatotic Liver Disease
Metabolic dysfunction-associated steatotic liver disease is estimated to affect about 32.4% of the world’s population.
Read MorePosted by Chris Wolski | Nov 22, 2023 | Disease States |
Metabolic dysfunction-associated steatotic liver disease is estimated to affect about 32.4% of the world’s population.
Read MorePosted by Andy Lundin | Oct 31, 2023 | Cardiovascular |
Next-gen cardiometabolic biomarkers will aid earlier detection of risk factors for obesity, diabetes, and heart disease in children.
Read MorePosted by Andy Lundin | Oct 27, 2023 | Dementias & Alzheimer’s |
Indiana University School of Medicine researchers will play key roles in a consortium studying biomarkers for Alzheimer’s diagnosis.
Read MorePosted by Andy Lundin | Sep 14, 2023 | Gastrointestinal Infections |
Cairn Diagnostics’ 13C-Spirulina Gastric Emptying Breath Test was included in ACG Clinical Guidelines for the diagnosis of gastroparesis.
Read MorePosted by Chris Wolski | Sep 6, 2023 | Lab Management |
Understanding the prevalence of pharmacies and lab capacity to accelerate test and treat opportunities, improves the health care enterprise.
Read More